IIT Roorkee researchers develop novel drug candidate to restore strength of antibiotics against drug-resistant bacteria
The research team is led by Prof. Ranjana Pathania from the Department of Biosciences and Bioengineering, IIT Roorkee, and includes Dr. Mangal Singh and Perwez Bakht, as well as along with Norwegian collaborators Prof. Annette Bayer and her team from UiT Tromsø.
Also read: IIT-KGP appoints dean to look after students' well-being following multiple suicides
The team designed a novel molecule that works alongside the antibiotic Meropenem to treat infections caused by KPC-2-producing Klebsiella pneumoniae, a superbug listed among the World Health Organization's top-priority threats, IIT Roorkee said in a statement.
It further added that the newly discovered molecule belongs to a class of β-lactamase inhibitor drugs that prevent bacterial enzymes from breaking down life-saving antibiotics.
Speaking about the new discovery, Prof. Pathania said that the breakthrough offers a promising solution to one of the world's most urgent health challenges, antimicrobial resistance.
'Our compound neutralizes the resistance mechanism and shows strong therapeutic results in preclinical models,' she added.
Also read: IIT Guwahati to establish Manekshaw centres for defence & national security research
Prof. K. K. Pant, Director of IIT Roorkee, said that the innovation reflects IIT Roorkee's commitment to developing impactful scientific solutions for global challenges.
'In the face of rising antibiotic resistance, such research provides critical hope for effective and accessible treatments,' Prof. Pant added.
It may be mentioned here that the research has been published in the prestigious Journal of Medicinal Chemistry, and is expected to contribute significantly to future drug development efforts targeting superbugs.
Also read: Bright young minds should shape India's future: Prez Murmu at 45th convocation of IIT-ISM in Dhanbad
IIT Roorkee stated that the discovery marks a significant advancement in safeguarding public health, particularly at a time when antibiotic resistance is threatening global healthcare systems.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
21 minutes ago
- Time of India
IIT Bhubaneswar to set up research lab with investment of Rs 45 crore in SiCSem semiconductor unit
Academy Empower your mind, elevate your skills Indian Institute of Technology (IIT) Bhubaneswar will set up a research lab with an investment of Rs 45 crore in the SiCSem semiconductor unit , said Union Information and Technology Minister Ashwini Vaishnaw on one of the companies that recieved approval to build its semiconductor plant with an investment of Rs 2,066 crore, is collaborating with Clas-SiC Wafer Fab, UK, to establish an integrated facility of Silicon Carbide (SiC) based Compound Semiconductors in Info Valley, Bhubaneshwar, will be the first commercial compound fab in the country. The project proposes to manufacture Silicon Carbide devices. This compound semiconductor fab will have an annual capacity of 60,000 wafers and a packaging capacity of 96 million units, according to the official proposed products will have applications in missiles, defence equipment, electric vehicles (EVs), railway, fast chargers, data centre racks, consumer appliances, and solar power Union Minister informed that giant tech firms such as Intel and Lockheed Martin have made their investments in the company. He said that this plant will be "the most advanced plant in the world."Union Minister said that all four semiconductor plants approved by the Cabinet will start their construction work very to the media persons after the announcement of the Cabinet's decision in the national capital, Union Minister said, "All four Plants will start their construction work very soon. As you have seen in the case of the first six Plants, the permissions and everything came in a record time, within 100 days most of the time, and within 6 months they started their design and construction. Same progress, we think, we will have in this.""CMs of Andhra Pradesh and Odisha spoke with me just now. They thanked the Prime Minister and they committed that they will start the construction work in record time," Vaishnaw a significant push to India's chip-making ambitions , the Centre approved four new semiconductor manufacturing projects with a total investment of Rs 4,600 crore under the India Semiconductor Mission (ISM).The projects will boost domestic production of chips, packaging and advanced materials, generating over 2,000 skilled jobs Union Minister also apprised the status of the six under-construction semiconductor plants in different parts of the country, adding that all of them are making "good" progress and very soon the country will deliver its first domestically-produced of the four projects that have been approved, two are in Odisha, one in Punjab, and one in Andhra approvals take the total India Semiconductor Mission (ISM) portfolio to 10 projects across six states with cumulative investments of Rs 1.6 lakh crore. The government said the move is in line with its vision of building a robust and self-reliant semiconductor ecosystem to support sectors ranging from defence to consumer of the approved projects will come up in Odisha's Info Valley, Bhubaneswar, making the state an emerging hub for the May, the Union Cabinet approved India's sixth semiconductor manufacturing unit in Jewar in western Uttar Pradesh. It will be established near Jewar Airport through a joint venture between the HCL Group and Taiwanese electronics giant sixth unit is expected to generate employment for around 2,000 people and will help significantly in strengthening India's semiconductor ecosystem. The unit at Jewar will have a 20,000 wafers per month capacity, and the chips will have 36 million (3.6 crore) per other five semiconductor plants, four are in Gujarat: Tata Electronics-PSMC Semiconductor fab, CG Power-Renesas-Stars Microelectronics ATMP unit , Micron Technology's ATMP unit and Kaynes Semicon ATMP unit, while the Tata Semiconductor Assembly and Test (TSAT) Unit is in Assam.
&w=3840&q=100)
First Post
an hour ago
- First Post
India boosts semiconductor manufacturing with Rs 4,600 cr Cabinet approval for 4 new units
The Union Cabinet, led by Prime Minister Narendra Modi, has approved four new semiconductor projects worth ₹4,600 crore under the India Semiconductor Mission, boosting local chip manufacturing and creating 2,000 skilled jobs read more The Union Cabinet, led by Prime Minister Narendra Modi, authorised four additional semiconductor manufacturing projects on Tuesday, totalling Rs 4,600 crore under the India Semiconductor Mission (ISM). The initiatives will increase local manufacturing of chips, packaging, and innovative materials, creating approximately 2,000 skilled jobs immediately. Two of the four approved projects are located in Odisha, one in Punjab, and one in Andhra Pradesh. 'Four new semiconductor projects have been approved. You know that six projects are already approved and four new ones have been added to it today. These are in Odisha, Andhra Pradesh and Punjab, at an investment of Rs 4,594 Crore,' Union Minister Ashwini Vaishnaw said at a press conference in New Delhi today. STORY CONTINUES BELOW THIS AD The approvals bring the whole India Semiconductor Mission (ISM) portfolio to ten projects across six states, with a combined investment of Rs 1.6 lakh crore. The government stated that the action is consistent with its objective of developing a robust and self-sufficient semiconductor ecosystem to assist industries ranging from military to consumer devices. Two of the approved projects will be developed in Odisha's Info Valley, Bhubaneswar, establishing the state as an emerging hub for the industry. SiCSem Private Limited will establish the country's first commercial compound semiconductor manufacturing factory, capable of generating 60,000 wafers per year and packaging 96 million units. The plant's goods will find use in electric cars, railroads, rapid chargers, data centres, solar inverters, consumer appliances, and missile systems. The second Odisha project, by 3D Glass Solutions Inc. (3DGS), will establish an advanced packaging and embedded glass substrate facility. It will introduce the world's most advanced semiconductor packaging technology to India, with an annual capacity of 69,600 glass panel substrates, 50 million assembled units and 13,200 3D Heterogeneous Integration (3DHI) modules. The technology will be used in high-performance computing, artificial intelligence, defence electronics, radio frequency and photonics applications. In Andhra Pradesh, Advanced System in Package (ASIP) Technologies, in collaboration with South Korea's APACT Co. Ltd., will set up a semiconductor manufacturing unit with a capacity of 96 million units a year. The plant will serve markets for mobile devices, set-top boxes, automotive electronics and other applications. The fourth project that was approved by the Union Cabinet is for Continental Device India Ltd. (CDIL) in Mohali, Punjab, it will expand the company's discrete semiconductor manufacturing capacity. The upgraded facility will produce 158.38 million units of high-power devices annually, including MOSFETs, IGBTs, Schottky diodes and transistors in both silicon and silicon carbide. These components are used in EV electronics, renewable energy systems, power conversion, industrial automation and communication infrastructure. STORY CONTINUES BELOW THIS AD The approvals mark a decisive step in positioning India as a global semiconductor hub. 'These projects will accelerate our journey towards Atmanirbhar Bharat in electronics manufacturing and create a talent pool that will serve global industry,' the government said in a statement. The ISM has already attracted major investments and fostered a growing design ecosystem, with 72 startups and 278 academic institutions engaged in semiconductor R&D and training. Over 60,000 students are benefitting from semiconductor talent development programmes across the country.
Time of India
2 hours ago
- Time of India
IIT Roorkee scientists reveal how this common herb could defeat world's most dangerous superbugs & enhance antibiotic power
A research team at IIT Roorkee has found that a natural compound called thymol may help weaken stubborn superbugs and improve the effectiveness of antibiotics. Thymol is a plant-based substance commonly found in thyme. The study suggests it can target persister cells , bacteria that survive treatment and cause long-lasting infections, especially in Acinetobacter baumannii . This bacterium is known for causing persistent and chronic infections in hospitals. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program The findings, published in the Antimicrobial Agents and Chemotherapy journal, also show that thymol may make powerful antibiotics like meropenem work better. Early results indicate that using thymol alongside meropenem increases the antibiotic's ability to fight infections. This could be a promising way to tackle persistent bacterial infections. Professor Ranjana Pathania, the lead researcher, said, 'Thymol's ability to break down bacterial persistence and boost existing antibiotics offers a hopeful path to address antimicrobial resistance .' Live Events She added, 'By focusing on persister cells, we may improve treatment for chronic and recurring infections.' The research team discovered that thymol attacks persister cells in several ways. It disrupts the bacteria's energy production, making survival harder. It also damages the bacteria's outer membrane, making them more vulnerable. Thymol produces reactive oxygen species (ROS) that stress and weaken bacteria. It also blocks bacterial efflux pumps, which can help antibiotics like meropenem work better. While these findings are encouraging, more research and clinical trials are needed to confirm thymol's use in real medical treatments. Professor K.K. Pant, Director of IIT Roorkee, said, 'Antimicrobial resistance is a major global problem. This study shows how natural compounds could help overcome persistent infections. It reflects our commitment to research that tackles important health challenges.' The next stage of research will focus on improving the thymol and meropenem combination and testing its potential through further studies. If successful in clinical trials, this approach could become a new weapon against antibiotic-resistant infections, the team said. Inputs from agencies
